首页> 外国专利> Compound, oligonucleotide analogue or a pharmaceutically acceptable salt thereof, pharmaceutical composition, and use of an oligonucleotide analog

Compound, oligonucleotide analogue or a pharmaceutically acceptable salt thereof, pharmaceutical composition, and use of an oligonucleotide analog

机译:化合物,寡核苷酸类似物或其药学上可接受的盐,药物组合物和寡核苷酸类似物的用途

摘要

"COMPOUND, OLIGONUCLEOTIDE ANALOG OR PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME, PHARMACEUTICAL COMPOSITION, AND USE OF AN OLIGONUCLEOTIDE ANALOG". This invention provides novel bicyclonucleoside analogs, which exhibit anti-AIDS activity and intermediates to produce oligonucleotide analogs, which have antisense or antigen activity as well as stability in vivo. The present invention relates to compounds of the following formula (1) or their pharmaceutically acceptable salts. R2 represents a hydrogen atom or a protecting group for a hydroxy group, R2 represents an azido group or an optionally protected amino group or the like, B represents a purin-9-yl group or a group 2 -oxo-1,2-dihydropyrimidin-1-yl, which are optionally substituted by substituents selected from the group 224 below (Group 244) halogen atom, alkyl group having 1-6 carbon atoms, hydroxy, mercapto group, amino group, and the like.
机译:“化合物,寡核苷酸类似物或相同的药物可接受的盐,药物组合物以及寡核苷酸类似物的使用”。本发明提供了新颖的双环核苷类似物,其具有抗艾滋病活性,并具有产生寡核苷酸类似物的中间体,该寡核苷酸类似物具有反义或抗原活性以及体内稳定性。本发明涉及下式(1)的化合物或其药学上可接受的盐。 R 2代表氢原子或羟基的保护基,R 2代表叠氮基或任选保护的氨基等,B代表嘌呤-9-基或2-氧-1,2-二氢嘧啶基-1-基,其任选地被选自下面的<224>组(<244>组)的卤原子,具有1-6个碳原子的烷基,羟基,巯基,氨基等的取代基取代。

著录项

  • 公开/公告号BR0012646A

    专利类型

  • 公开/公告日2002-04-09

    原文格式PDF

  • 申请/专利权人 SANKYO COMPANY LIMITED;

    申请/专利号BR20000012646

  • 发明设计人 TAKESHI IMANISHI;SATOSHI OBIKA;

    申请日2000-07-21

  • 分类号C07H19/167;C07H19/067;

  • 国家 BR

  • 入库时间 2022-08-22 00:46:10

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号